Benzinga | Nov 15, 2021 10:56AM EST

Homology Medicines Q2 EPS $(0.54) Beats $(0.59) Estimate, Sales $2.19M Beat $430.00K Estimate

Homology Medicines (NASDAQ:FIXX) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.59) by 8.47 percent. This is a 30.77 percent increase over losses of $(0.78) per share from the same period last year. The company reported quarterly sales of $2.19 million which beat the analyst consensus estimate of $430.00 thousand by 408.60 percent. This is a 285.71 percent increase over sales of $567.00 thousand the same period last year.